Sunday July 21, 2019
Home World Unlocking The...

Unlocking The Cage: A film about man’s quest to achieve legal rights for animals

“Unlocking The Cage” is all about one man’s quest to achieve legal rights for animals

3
//
Chimpanzee. Image source: interrete.org

Filmmakers D.A. Pennebaker and Chris Hegedus have come up with a new documentary called “Unlocking The Cage”. These 2 have collaborated on major award-winning films such as “The War Room, about Bill Clinton’s Presidential Campaign. In their new release, they have bought up their acute observational style of filmmaking.

According to npr.org, “Unlocking The Cage” is all about one man’s quest to achieve legal rights for animals. The whole plot is told from the Steven’s point of view (Steven Wise is a leading animal rights lawyer). In this film, he struggles in a New York Court to recognize a chimpanzee named Tommy as a person with limited legal rights. Above all the film is a sympathetic portrait of an advocate.

Poster of the film, "Unlocking the Cage". Image source: unlockingthecagethefilm.com
Poster of the film, “Unlocking the Cage”. Image source: unlockingthecagethefilm.com

Mr. Wise ideology is that “Animals should have the legal status of persons. What this means is not that they should be classified as human, but rather that their rights should be acknowledged and protected under the law.

Follow NewsGram at Facebook: NewsGram

In the film, he is portrayed as a rumpled man in his mid-60s who defends in front of skeptical judges and journalists. His clients are the chimpanzees living in New York State in what appear to be miserable conditions. The camera follows Mr. Wise and his colleagues for several years as they build a case that they hope will establish a new precedent.

In the end, Mr. Wise also remarks in the movie that “This is the end of the beginning.” Some of Mr. Wise’s Positions also seems to be questionable. For example: How can a being without human language or human culture have to stand to seek redress from human institutions?

Follow NewsGram at Twitter: @newsgram1

Hegedus believes that a cultural shift is taking place right now in the world. So he hopes that his film will last. The filmmakers believe that once it is out in the world its fate is out of their hands.

-by Pritam, an intern at Newsgram. Twitter: Pritam_Gogreen

ALSO READ:

 

  • Vrushali Mahajan

    Films like these should be appreciated to its best. We really need such kind of movies so that we understand the habits of animals and their rights

  • devika todi

    it should be ensured that such movies receive maximum appreciation and attention.

  • Paras Vashisth

    I really appreciate this because this types of films and documentaries create an impact on people’s minds which is very helpful to understand something.

SHARE
  • Vrushali Mahajan

    Films like these should be appreciated to its best. We really need such kind of movies so that we understand the habits of animals and their rights

  • devika todi

    it should be ensured that such movies receive maximum appreciation and attention.

  • Paras Vashisth

    I really appreciate this because this types of films and documentaries create an impact on people’s minds which is very helpful to understand something.

Next Story

Chinese Scientists to Start Testing Long-lasting HIV Vaccine on Humans

There are nearly 1.25 million HIV-positive patients in China, where around 80,000 people contract the disease every year, according to the National Health Commission

0
sexually transmitted disease
A nurse takes blood from a man for a free HIV test on a bus in Tehran, Dec. 16, 2015. VOA

A group of Chinese scientists will start trialing a long-lasting human immunodeficiency virus (HIV) vaccine on 160 volunteers, the first time that such a vaccine has reached a second-phase human trial, the official newspaper China Daily reported on Friday.

The candidate vaccine, known as DNA-rTV, relies on replication of the virus’ DNA to stimulate “effective immunization” against the virus, said Shao Yiming, an HIV researcher at the Chinese Centre for Disease Control and Prevention.

According to Shao, this vaccine — similar to the one used to prevent smallpox — is the first to undergo a second-phase human trial.

“With significant reduction of virulence, the vaccine will not cause infection in healthy receivers,” Shao was quoted as saying by Efe news.

Moreover, the vaccine being developed does not contain all segments of the virus but some parts of its genetic material, so that the chances of infection are significantly reduced, the report said.

The DNA of the virus will continue replicating after vaccination, thereby stimulating the immune system continuously to produce antibodies, a similar process to the one used by vaccines for other diseases.

HIV
Nearly 40 individual HPV types linked to HIV infection. Pixabay

Most of the HIV vaccines being developed in China and around the world are inactivated vaccines, which do not contain HIV DNA that can replicate, so their effect is not long-lasting.

The first phase of testing, started in 2007, proved the “safety” of the vaccine while the second phase will serve to determine the vaccination procedure to be followed in the future, Shao said.

“Hopefully, the second-phase trial will be completed in the latter half of 2021, and the third-phase clinical trial may start at the end of that year, which will involve thousands of volunteers in a trial to test the effectiveness of the vaccine to protect people against HIV,” he added.

Also Read: Cigarette Butts Significantly Reduce Plant Growth, Find Researchers

The research group has already recruited over 130 volunteers and initial work has begun in two Chinese hospitals, one in Beijing and another in Hangzhou in eastern China.

Chuang Chuang, head of Hangzhou Sunflower, a non-profit promoting lesbian, gay, bisexual, and transgender (LGBT) rights, told China Daily that over 100 volunteers had already registered with the organization after coming to know about the second phase.

There are nearly 1.25 million HIV-positive patients in China, where around 80,000 people contract the disease every year, according to the National Health Commission. (IANS)